Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The physiological iron pool, scientifically referred to as the labile iron pool (LIP), is a dynamic and chemically reactive reservoir of intracellular iron that is not sequestered within storage proteins like ferritin or functional proteins like heme (Kakhlon & Cabantchik, 2002, PMID: 12421643). This pool consists of iron in both ferrous (Fe2+) and ferric (Fe3+) states, complexed with low-molecular-weight ligands such as citrate, acetate, or amino acids, making it readily available for essential metabolic processes including DNA replication and mitochondrial respiration (Halliwell & Gutteridge, 2015). Because this iron is redox-active, its concentration is strictly regulated; an expansion of the pool can catalyze the production of highly reactive hydroxyl radicals through the Fenton reaction, leading to lipid peroxidation and a form of regulated cell death known as ferroptosis (Dixon et al., 2012, PMID: 22624694). In pathological conditions such as hereditary hemochromatosis or transfusion-dependent thalassemia, the LIP becomes pathologically enlarged, necessitating the use of iron chelators like deferoxamine or deferasirox to prevent organ damage (StatPearls, 2023). Conversely, in iron-deficiency anemia, the pool is depleted, and therapeutic intervention involves iron supplementation to restore the physiological levels required for healthy erythropoiesis (NIH, 2023). Monitoring this pool is critical in clinical settings, as it serves as a direct indicator of potential oxidative risk and therapeutic efficacy in iron-related disorders.
Iron chelators bind to the redox-active ions within the labile iron pool to form stable, non-toxic complexes that are subsequently excreted, thereby preventing the generation of reactive oxygen species via the Fenton reaction. In contrast, iron supplements provide exogenous iron to replenish this pool, ensuring sufficient availability for erythropoiesis and enzymatic functions.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological iron pool (LIP).